Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-22-005264
Filing Date
2022-04-01
Accepted
2022-04-01 08:05:45
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A crbp-proxy-notice-2022.htm DEFA14A 12500
2 GRAPHIC img65945892_0.jpg GRAPHIC 244920
3 GRAPHIC img65945892_1.jpg GRAPHIC 151771
  Complete submission text file 0000950170-22-005264.txt   550154
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37348 | Film No.: 22795870
SIC: 2834 Pharmaceutical Preparations